China Health Care Data Insights: Glucometer sales saw recovery; Yuwell benefitted from new CGM launches; Cofoe achieved rapid CGM market share gainsIssuing time:2025-08-08 00:00 In July 2025, glucometer GMV on major e-commerce platforms in China increased 24% y/y; BGM and CGM segments grew by 14% and 99%, respectively, both indicating robust market momentum. [Brand Breakdown, July 2025] - Yuwell: Glucometer GMV grew 65% y/y, with market share climbing 6 ppt to 24%, making Yuwell the leading player in the glucometer industry. BGM sales increased 21% y/y and market share reached 42%. CGM GMV approached RMB 36 mln, accounting for a 25% share, driven by strong contribution from its second-generation products. - Sinocare: Glucometer GMV rose 7% y/y, maintaining a 24% market share and ranking second. BGM sales grew 10% y/y, though market share declined by 2 ppt to 52%, still the highest in the BGM segment. CGM sales declined 6% y/y, with share at roughly 12%, reflecting continued online channel headwinds. - Cofoe: BGM GMV grew ~7% y/y, with market share near 3%. CGM GMV totaled nearly RMB 12 mln, with market share exceeding 8%. Other Chinese CGM brands outperformed as well: SIBIONICS and MicroTech recorded GMV y/y growth of 153% and 177%, respectively, well ahead of international competitor Abbott, which saw a 22% y/y decline.
Article classification:
Topical Insights
|